美奥舒组织切除系统治疗宫内良性占位病变的临床分析

发布时间：2018-02-24 21:55

本文关键词： 美奥舒组织切除系统黏膜下肌瘤子宫内膜息肉　出处：《现代妇产科进展》2017年06期 　论文类型：期刊论文

【摘要】：目的:探讨美奥舒治疗子宫内膜息肉和黏膜下肌瘤的安全性和有效性。方法:回顾分析2013年9月至2016年4月于湖北省妇幼保健院行美奥舒治疗的99例子宫内膜息肉和黏膜下肌瘤患者的临床资料。采用子宫肌瘤生活质量评估量表(UFS-QOL)的症状严重程度评分表(SSS)及月经期症状评分表评估患者的月经及临床症状情况。结果:99例患者手术均成功,无严重并发症发生。黏膜下肌瘤和内膜息肉的手术时间分别为(5.6±4.9)min和(2.6±1.5)min,平均出血量(15.35±5.8)ml。手术前SSS评分及月经期评分为(29.72±4.60)分和(10.17±2.67)分,术后3月评分分别为(14.99±3.40)分和(3.53±1.40)分,术后6月评分分别为(14.18±3.30)分和(3.15±1.60)分;手术前后评分比较,差异均有统计学意义(P0.05)。术后患者的月经量明显减少,经期缩短,不规则阴道出血、痛经等症状得到明显改善,贫血均得到纠正,患者满意率95.96%(95/99)。结论:美奥舒治疗子宫黏膜下肌瘤和子宫内膜息肉微创、安全、有效。
[Abstract]:Objective: to investigate the safety and efficacy of meosol in the treatment of endometrial polyps and submucous leiomyomas. Methods: 99 cases of endometrium treated with meosol from September 2013 to April 2016 in Hubei Provincial Maternal and Child Health Hospital were retrospectively analyzed. Clinical data of patients with myoma of meat and submucous membrane. The symptom severity scale (SSS) and menstrual symptom scale (SSS) of UFS-QOLwere used to evaluate the menstrual and clinical symptoms of the patients. There were no serious complications. The operative time of submucous myoma and endometrial polyp were 5.6 卤4.9 min and 2.6 卤1.5 min, respectively. The mean blood loss was 15.35 卤5.8 ml. The scores of SSS and menstrual period before operation were 29.72 卤4.60 and 10.17 卤2.67, and on March, the scores were 14.99 卤3.40 and 3.53 卤1.40, respectively. On June, the scores were 14. 18 卤3. 30 and 3. 15 卤1. 60, respectively. There were significant differences in the scores before and after operation (P 0. 05). The menstrual volume, menstrual period, irregular vaginal bleeding, dysmenorrhea and other symptoms were significantly improved. The patients' satisfaction rate was 95.96 / 95 / 990.Conclusion: meosol is safe and effective in the treatment of submucous myoma and endometrial polyp.
【作者单位】：湖北省妇幼保健院妇科;
【基金】：湖北省卫生厅青年科技人才项目(No:QJX2010-39)
【分类号】：R713.4

【相似文献】